Nicolás Merchante (Nicolas Merchante, N Merchante)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 8

Top Venues

JAC-antimicrobial resistance

Journal of viral hepatitis

Open forum infectious diseases

Antimicrobial agents and chemotherapy

Servicio Andaluz de Salud

Universidad de Sevilla (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Servicio Andaluz de Salud Jul 01 2007

Spain

Facultativo Especialista de Área :: Medicina Interna-Enfermedades Infecciosas

Education History

Universidad de Sevilla Dec 14 2015

Spain

PHD :: Medicina

Universidad de Sevilla Oct 01 2012 - Jul 31 2013

Spain

MSC

Publications

Nicolás Merchante, Rocío Herrero, María Dolores Valverde-Fredet, Miguel Rodríguez-Fernández, Héctor Pinagorte, Francisco J Martínez-Marcos, Concepción Gil-Anguita, María García-López, María Tasias Pitarch, Vicente Abril López De Medrano, Miguel Nicolás Navarrete Lorite, Cristina Gómez-Ayerbe, Eva León, Pilar González-De La Aleja, Ana Ruiz Castillo, Ana I Aller, Juan Carlos Rodríguez-Diaz, Julia Ternero Fonseca, Juan E Corzo, Alberto Naranjo Pérez, Marta Trigo-Rodríguez, Esperanza Merino
Role of previous systemic antibiotic therapy on the probability of recurrence after an initial episode of Clostridioides difficile infection treated with vancomycin. JAC-antimicrobial resistance 5 (2) (2023)
Nicolás Merchante, Rocío Herrero, María Dolores Valverde-Fredet, Miguel Rodríguez-Fernández, Héctor Pinagorte, Francisco J Martínez-Marcos, Concepción Gil-Anguita, María García-López, María Tasias Pitarch, Vicente Abril López De Medrano, Miguel Nicolás Navarrete Lorite, Cristina Gómez-Ayerbe, Eva León, Pilar González-De La Aleja, Ana Ruiz Castillo, Ana I Aller, Juan Carlos Rodríguez-Diaz, Julia Ternero Fonseca, Juan E Corzo, Alberto Naranjo Pérez, Marta Trigo-Rodríguez, Esperanza Merino
Role of previous systemic antibiotic therapy on the probability of recurrence after an initial episode of Clostridioides difficile infection treated with vancomycin. JAC-antimicrobial resistance 5 (2) (2023)
Marta Trigo-Rodríguez, Sheila Cárcel, Ana Navas, Reinaldo Espíndola-Gómez, José Carlos Garrido-Gracia, María Ángeles Esteban Moreno, Rafael León-López, Pedro María Martínez Pérez-Crespo, Eduardo Aguilar Alonso, David Vinuesa García, Alberto Romero, Inés Pérez Camacho, Belén Gutiérrez Gutiérrez, Francisco Javier Martínez-Marcos, Concepción Fernández-Roldán, Eva León, Alexandra Aceituno Caño, Juan E Corzo-Delgado, Elena Perez-Nadales, Cristina Riazzo, Carmen de la Fuente, Aurora Jurado Roger, Julian Torre-Cisneros, Nicolás Merchante
Role of IP-10 to Predict Clinical Progression and Response to IL-6 Blockade With Sarilumab in Early COVID-19 Pneumonia. A Subanalysis of the SARICOR Clinical Trial. Open forum infectious diseases 10 (4) (2023)
Miguel Rodríguez-Fernández, Reinaldo Espíndola Gómez, Marta Trigo-Rodríguez, Carmen Castro, Pedro Martínez Pérez-Crespo, Rocío Herrero, Eva M León, Samuel Bernal, Juan E Corzo, Nicolás Merchante
High incidence of asymptomatic phase I IgG seroconversion after acute Q fever episode: implications for chronic Q fever diagnosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
Nicolás Merchante, Sheila Cárcel, José Carlos Garrido-Gracia, Marta Trigo-Rodríguez, María Ángeles Esteban Moreno, Rafael León-López, Reinaldo Espíndola-Gómez, Eduardo Aguilar Alonso, David Vinuesa García, Alberto Romero-Palacios, Inés Pérez-Camacho, Belén Gutiérrez Gutiérrez, Francisco Javier Martínez-Marcos, Concepción Fernández-Roldán, Pedro María Martínez Pérez-Crespo, Alexandra Aceituno Caño, Eva León, Juan E Corzo, Carmen de la Fuente, Julian Torre-Cisneros
Early Use of Sarilumab in Patients Hospitalized with COVID-19 Pneumonia and Features of Systemic Inflammation: the SARICOR Randomized Clinical Trial. Antimicrobial agents and chemotherapy 66 (2) (2021)
Víctor Sapena, Marco Enea, Ferràn Torres, Ciro Celsa, Jose Ríos, Giacomo Emanuele Maria Rizzo, Pierre Nahon, Zoe Mariño, Ryosuke Tateishi, Tatsuya Minami, Angelo Sangiovanni, Xavier Forns, Hidenori Toyoda, Stefano Brillanti, Fabio Conti, Elisabetta Degasperi, Ming-Lung Yu, Pei-Chien Tsai, Kévin Jean, Mohamed El Kassas, Hend Ibrahim Shousha, Ashraf Omar, Claudio Zavaglia, Hiroko Nagata, Mina Nakagawa, Yasuhiro Asahina, Amit G Singal, Caitlin C Murphy, Mohamed Ahmed Samy Kohla, Chiara Masetti, Jean-François Dufour, Nicolás Merchante, Luisa Cavalletto, Liliana Lc Chemello, Stanislas Pol, Javier Crespo, Jose Luis Calleja, Rosanna Villani, Gaetano Serviddio, Alberto Zanetto, Sarah Shalaby, Francesco Paolo Russo, Rob Bielen, Franco Trevisani, Calogero Cammà, Jordi Bruix, Giuseppe Cabibbo, Maria Reig
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis. Gut (2021)
Juan Macías, Rafael Granados, Francisco Téllez, Dolores Merino, Montserrat Pérez, Luis E Morano, Rosario Palacios, María Paniagua, Mario Frías, Nicolás Merchante, Juan Antonio Pineda, null null
Similar recovery of liver function after response to all-oral HCV therapy in patients with cirrhosis with and without HIV coinfection. Journal of viral hepatitis 26 (1) (2018)
Nicolás Merchante, T Aldámiz-Echevarría, M García-Álvarez, Antonio Rivero, Juan Macías, P Miralles, M A Jiménez-Sousa, M Mancebo, L Pérez-Latorre, D Pineda-Tenor, Juan Berenguer, Salvador Resino García, Juan Antonio Pineda
Bacterial translocation and clinical progression of HCV-related cirrhosis in HIV-infected patients. Journal of viral hepatitis 25 (2) (2017)

Nicolás Merchante.css-eqlu8i{font-size:small;padding-left:4px;} (Nicolas Merchante, N Merchante)

Publication Activity (10 Years)

Top Topics

Top Venues

Nicolás Merchante (Nicolas Merchante, N Merchante)